OBJECTIVE: To describe the clinical, neuropsychologic, and radiologic features of a family with a C31LfsX35 mutation in the progranulin gene CCDS11483.1). DESIGN: Case series. PATIENTS: A large British kindred (DRC255) with a PGRN mutation was assessed. Affected individuals presented with a mean age of 57.8 years (range, 54-67 years) and a mean disease duration of 6.1 years (range, 2-11 years). RESULTS: All patients exhibited a clinical and radiologic phenotype compatible with frontotemporal lobar degeneration based on current consensus criteria. However, unlike sporadic frontotemporal lobar degeneration, parietal deficits, consisting of dyscalculia, visuoperceptual /visuospatial dysfunction, and/or limb apraxia, were a common feature, and brain imaging showed posterior extension of frontotemporal atrophy to involve the parietal lobes. Other common clinical features included language output impairment with either dynamic aphasia or nonfluent aphasia and a behavioral syndrome dominated by apathy. CONCLUSION: We suggest that parietal deficits may be a prominent feature of PGRN mutations and that these deficits may be caused by disruption of frontoparietal functional pathways.
OBJECTIVE: To describe the clinical, neuropsychologic, and radiologic features of a family with a C31LfsX35 mutation in the progranulin gene CCDS11483.1). DESIGN: Case series. PATIENTS: A large British kindred (DRC255) with a PGRN mutation was assessed. Affected individuals presented with a mean age of 57.8 years (range, 54-67 years) and a mean disease duration of 6.1 years (range, 2-11 years). RESULTS: All patients exhibited a clinical and radiologic phenotype compatible with frontotemporal lobar degeneration based on current consensus criteria. However, unlike sporadic frontotemporal lobar degeneration, parietal deficits, consisting of dyscalculia, visuoperceptual /visuospatial dysfunction, and/or limb apraxia, were a common feature, and brain imaging showed posterior extension of frontotemporal atrophy to involve the parietal lobes. Other common clinical features included language output impairment with either dynamic aphasia or nonfluent aphasia and a behavioral syndrome dominated by apathy. CONCLUSION: We suggest that parietal deficits may be a prominent feature of PGRN mutations and that these deficits may be caused by disruption of frontoparietal functional pathways.
Authors: Iraad F Bronner; Patrizia Rizzu; Harro Seelaar; Saskia E van Mil; Burcu Anar; Asma Azmani; Laura Donker Kaat; Sonia Rosso; Peter Heutink; John C van Swieten Journal: Eur J Hum Genet Date: 2007-01-17 Impact factor: 4.246
Authors: D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson Journal: Neurology Date: 1998-12 Impact factor: 9.910
Authors: Jennifer L Whitwell; Clifford R Jack; Matthew Baker; Rosa Rademakers; Jennifer Adamson; Bradley F Boeve; David S Knopman; Joseph F Parisi; Ronald C Petersen; Dennis W Dickson; Michael L Hutton; Keith A Josephs Journal: Arch Neurol Date: 2007-03
Authors: B F Boeve; D M Maraganore; J E Parisi; J E Ahlskog; N Graff-Radford; R J Caselli; D W Dickson; E Kokmen; R C Petersen Journal: Neurology Date: 1999-09-11 Impact factor: 9.910
Authors: W Liu; B L Miller; J H Kramer; K Rankin; C Wyss-Coray; R Gearhart; L Phengrasamy; M Weiner; H J Rosen Journal: Neurology Date: 2004-03-09 Impact factor: 9.910
Authors: Prudence M Stanford; William S Brooks; Erdahl T Teber; Marianne Hallupp; Catriona McLean; Glenda M Halliday; Ralph N Martins; John B J Kwok; Peter R Schofield Journal: J Neurol Date: 2004-09 Impact factor: 4.849
Authors: Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton Journal: Nature Date: 2006-07-16 Impact factor: 49.962
Authors: J L Whitwell; C R Jack; B F Boeve; M L Senjem; M Baker; R Rademakers; R J Ivnik; D S Knopman; Z K Wszolek; R C Petersen; K A Josephs Journal: Neurology Date: 2009-03-03 Impact factor: 9.910
Authors: Maria Carmela Tartaglia; Manu Sidhu; Victor Laluz; Caroline Racine; Gil D Rabinovici; Kelly Creighton; Anna Karydas; Rosa Rademakers; Eric J Huang; Bruce L Miller; Stephen J DeArmond; William W Seeley Journal: Acta Neuropathol Date: 2009-10-30 Impact factor: 17.088
Authors: Claudia Jacova; Ging-Yuek R Hsiung; Itthipol Tawankanjanachot; Katie Dinelle; Siobhan McCormick; Marjorie Gonzalez; Hyunsoo Lee; Pheth Sengdy; Phoenix Bouchard-Kerr; Matthew Baker; Rosa Rademakers; Vesna Sossi; A Jon Stoessl; Howard H Feldman; Ian R Mackenzie Journal: Neurology Date: 2013-09-04 Impact factor: 9.910
Authors: Chiara Fenoglio; Daniela Galimberti; Francesca Cortini; John S K Kauwe; Carlos Cruchaga; Eliana Venturelli; Chiara Villa; Maria Serpente; Diego Scalabrini; Kevin Mayo; Laura M Piccio; Francesca Clerici; Diego Albani; Claudio Mariani; Gianluigi Forloni; Nereo Bresolin; Alison M Goate; Elio Scarpini Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472
Authors: N Makris; M G Preti; D Wassermann; Y Rathi; G M Papadimitriou; C Yergatian; B C Dickerson; M E Shenton; M Kubicki Journal: Brain Imaging Behav Date: 2013-09 Impact factor: 3.978
Authors: Jonathan D Rohrer; Gerard R Ridgway; Sebastian J Crutch; Julia Hailstone; Johanna C Goll; Matthew J Clarkson; Simon Mead; Jonathan Beck; Cath Mummery; Sebastien Ourselin; Elizabeth K Warrington; Martin N Rossor; Jason D Warren Journal: Neuroimage Date: 2009-08-11 Impact factor: 6.556